Unknown genetic predisposition in familial breast cancer can lie deep in family tree San Ming Wang University of Nebraska Medical Center.

Slides:



Advertisements
Similar presentations
Applications of HGP Genetic testing Forensics. Testing for a pathogenic mutation in a certain gene in an individual that indicate a persons risk of developing.
Advertisements

Hereditary GI Cancer Syndromes: Keys to identify high risk patients
Genomics-Based Personalized Healthcare Presented by: Charis Eng, MD, PhD -Chair & Director -Genomic Medicine Institute -Director -Center for Personalized.
Cancer: a genetic disease of inherited and somatic mutations n Gene mutations and/or genetic instability are involved in many cancers. n Viruses and environmental.
Genetics 101/Clinical Significance Camp Sunshine July 22, 2013 Diamond Blackfan Anemia Foundation Diamond Blackfan Anemia Canada.
Maryam Nazir. Personal Genomics:  Branch of genomics concerned with the sequencing and analysis of the genome of an individual  Once sequenced, it can.
Medical Genomics Promise, Peril and Price. Alison J Whelan M.D., FACP Professor of Medicine and Pediatrics Director of the Hereditary Cancer Clinic Washington.
Gene 210 Cancer Genomics April 29, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Genome-wide Association Study Focus on association between SNPs and traits Tendency – Larger and larger sample size – Use of more narrowly defined phenotypes(blood.
A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
Investigating the BRCA1 Mutation F.R.E.S.H Docs. Angelina Jolie Actress, Film director, and Screenwriter Mother had Breast Cancer and died at 56 from.
The Genetics of Breast and Ovarian Cancer Susceptibility Patricia Tonin, PhD Associate Professor Depts. Medicine, Human Genetics & Oncology McGill University.
Gene 210 Cancer Genomics May 5, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Aspects of Genetics and Genomics in Cancer Research Li Hsu Biostatistics and Biomathematics Program Fred Hutchinson Cancer Research Center.
Positional Cloning LOD Sib pairs Chromosome Region Association Study Genetics Genomics Physical Mapping/ Sequencing Candidate Gene Selection/ Polymorphism.
Something related to genetics? Dr. Lars Eijssen. Bioinformatics to understand studies in genomics – São Paulo – June Image:
An Update in Genetics of Epilepsy
“An integrated encyclopedia of DNA elements in the human genome” ENCODE Project Consortium. Nature 2012 Sep 6; 489: Michael M. Hoffman University.
BRCA Genes Dallas Henson.
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
Haplotype Discovery and Modeling. Identification of genes Identify the Phenotype MapClone.
Whole Exome Sequencing for Variant Discovery and Prioritisation
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
Introduction to BST775: Statistical Methods for Genetic Analysis I Course master: Degui Zhi, Ph.D. Assistant professor Section on Statistical Genetics.
COMPUTING OF THE RAD51 -BRCA2 INTERACTIONS Assist. Prof. Albena Todorova, PhD Andrey Kirov, Msc Peycho Petkov, PhD Computing of the effects of genetic.
Angelina Jolie The White Coat Wonder. Rational  The purpose of our research is to enrich the Premed-A community with the knowledge of other cancers caused.
About OMICS Group OMICS Group is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in.
The Center for Medical Genomics facilitates cutting-edge research with state-of-the-art genomic technologies for studying gene expression and genetics,
Genetics-multistep tumorigenesis genomic integrity & cancer Sections from Weinberg’s ‘the biology of Cancer’ Cancer genetics and genomics Selected.
Next-Generation Sequencing
Next Generation Sequencing and its data analysis challenges Background Alignment and Assembly Applications Genome Epigenome Transcriptome.
By Michelle Njoroge. What are genetics? noun ( used with a singular verb ) 1. Biology. the science of heredity, dealing with resemblances and differences.
The medical relevance of genome variability Gabor T. Marth, D.Sc. Department of Biology, Boston College Medical Genomics Course – Debrecen,
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
MPL Identification of alternative spliced mRNA variants related to cancers by genome-wide ESTs alignment KIM DAE SOO Oncogene Apr.
Molecular medicine - 2.
Next-Generation Sequencing Eric Jorgenson Epidemiology 217 2/28/12.
Breast Cancer and Ethical Issues Regarding Insurance Coverage! By Jenn Butt Heidi Keefe Melissa Snyder Rachel Malinowski.
Your genome: What does your DNA say about you? Personal Genetics Education Project (pgEd) Harvard Medical School personal genetics education.
Breast Ovarian Hereditary Breast & Ovarian Cancer Knowing one’s family medical history can be life-saving.
Lecture 6. Functional Genomics: DNA microarrays and re-sequencing individual genomes by hybridization.
Genetic Cancer Susceptibility (GCS) Genomics in I4C James McKay.
HW2: exome sequencing and complex disease Jacquemin Jonathan de Bournonville Sébastien.
Lecture-3 EXOME SEQUENCING Huseyin Tombuloglu, Phd GBE423 Genomics & Proteomics.
Paolo Vineis University of Torino and ISI Foundation, Torino, Italy address: GENE-ENVIRONMENT INTERACTIONS IN CANCER.
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Cancer Genetics Session 4 Medical Genetics.
Epigenetics: from Inheritance to Cancer Maxwell Lee National Cancer Institute Center for Cancer Research Laboratory of Population Genetics April 21, 2011.
Computational Biology and Genomics at Boston College Biology Gabor T. Marth Department of Biology, Boston College
Familial coronary artery disease Paul Brennan Clinical Director Northern Genetics Service Newcastle Hospitals NHS Foundation Trust North East and North.
Analyzing DNA using Microarray and Next Generation Sequencing (1) Background SNP Array Basic design Applications: CNV, LOH, GWAS Deep sequencing Alignment.
INTERPRETING GENETIC MUTATIONAL DATA FOR CLINICAL ONCOLOGY Ben Ho Park, M.D., Ph.D. Associate Professor of Oncology Johns Hopkins University May 2014.
Analysis of Next Generation Sequence Data BIOST /06/2015.
What Percentage of Cancer is Considered to be Hereditary?
Genomic Medicine Rebecca Tay Oncology Registrar. What is Genomic Medicine? personalised, precision or stratified medicine.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
1 Finding disease genes: A challenge for Medicine, Mathematics and Computer Science Andrew Collins, Professor of Genetic Epidemiology and Bioinformatics.
Hereditary Cancer Predisposition: Updates in Genetic Testing
Nucleotide variation in the human genome
Complex disease and long-range regulation: Interpreting the GWAS using a Dual Colour Transgenesis Strategy in Zebrafish.
Family Tree Presentation
Patient VB Li-Fraumeni Syndrome.
Who in the room would offer BRCA1/2 testing to this patient Who in the room would offer BRCA1/2 testing to this patient? How might the medical management.
Genomic Instability and Cancer
Epidemiology 101 Epidemiology is the study of the distribution and determinants of health-related states in populations Study design is a key component.
Genetics and Breast Cancer Adelphi 2018 Educational Forum Sharona Cohen, MS, CGC Certified Genetic Counselor Northwell Health.
How will cancer be treated in the 21st century?
Medical genomics BI420 Department of Biology, Boston College
Medical genomics BI420 Department of Biology, Boston College
Specific Tumor Suppressor Genes
Concordance between the genomic landscape identified by whole-exome sequencing of plasma cfDNA and tumor; DNA and recurrence of KDR/VEGFR2 oncogenic mutations.
Presentation transcript:

Unknown genetic predisposition in familial breast cancer can lie deep in family tree San Ming Wang University of Nebraska Medical Center

Genetically defined breast cancer Sporadic Breast Cancer caused by somatic mutation 90% of breast cancer – “ bad luck” Familial Breast Cancer caused by germline mutation 10% of breast cancer - inherited

Familial Breast Cancer In 1866, French physician Paul Broca reported 10 women over four generations in his wife’s family died from breast cancer

Genetic predisposition is the major factor for familial breast cancer Factors contributing to cancer include environment, life style, nutrition, infection, genetics etc. Genetic predisposition is considered as the major factor responsible for familial breast cancer Familial breast cancer is a genetic disease

BRCAx familial breast cancer Germline mutations in BRCA1 and BRCA 2 genes are known genetic predispositions for familial breast cancer Germline mutations in BRCA1 and BRCA 2 genes are present in 10-20% of familial breast cancer Predispositions for 40-50% of FBC are known Predispositions for 50-60% of FBC remain unknown

Efforts made to identify the unknown predispositions linkage analysis, positional cloning, genomic arrays, targeted sequencing, GWAS, exome sequencing have been applied Large sample sizes of tenth of thousand cases per study are routinely used Newly identified predispositions are very limited

Newly identified predisposition are all rare PredispositionBC cases References with mutation XRCC23,3715Park et al, 2012 XRCC23,5480Hilbers et al, 2012 FANCC1,4351Tompson et al, 2012 BLM1,4354Tompson et al, 2012 BRIP1/BACH13572Cao et al PPM1D6,63421Ruark et al. Total 16,78933 (0.5%)

The rarity makes it indistinguishable between disease and normal population Identified rare germline mutations in XRCC2 in 5 out of 3,371 BRCA1/2-negative familial breast cancer cases. (Park, et al. Am J Hum Genet. (4):734-9, 2012) The same mutation failed to be detected in another 3,548 BRCA1/2-negative familial breast cancer cases but in 1 of 1,435 normal control (Hilbers et al. J Med Genet. 49(10):618-20, 2012)

Current theory to explain germline predispositions in familial breast cancer High-risk genes: rare mutations convey high- risk, such as BRCA1; Intermediate-risk genes: rare mutations convey intermediate risk, such as CHEK2; Modest risk genetic variants: common genetic variants such as the SNPs detected by GWAS population studies

Distribution of known genetic predispositions Fanale et al. Oncogene 31(17):2121-8, 2012

Question: frequency of unknown predispositions 100% 40% Existing ?

Hypothesis: Unknown predisposition can be family-specific FBC is an autosomal dominant disease Each family is enriched with the predisposition Focus on family may have higher chance to identify the unknown predisposition than population screening (diluted)

Studies in BRCAx families

Exome sequencing Next-generation sequencing-based >180,000 exons from around 20,000 genes in the human genome 1/100 genome DNA content 1/5 cost of sequencing whole genome ($1,000) 85% of known genetic diseases are caused by mutation in exon ! Next-generation DNA sequencing Genome Exome Sequencing

Germline mutations in three BRCAx families are highly family-specific

Putative genetic predisposition in each BRCAx family GenePositionChangeDistribution Family 1 PINK1chr1: A>G USP28chr11: A>G TIGD2chr4: C>T Family 2 KAT6Bchr10: G>T KAT6Bchr10: C>T NOTCH2chr1: C>T Family 3 ADCY9chr16: G>A+-+-- PHKBchr16: G>T+--+- NANPchr20: A>G-++-- PPP6R2chr22: C>A---++

KAT6B

A histone acetyl-transferase Its N-terminal is involved in transcriptional repression while its C- terminal is involved in transcriptional activation Interacts with important transcriptional regulators RUNX1 and RUNX2. A component of the MOZ/MORF complex involved in DNA replication, transcriptional regulation, and epigenetic modification of chromatin structure Mutations cause several neural genetic disease Not known involved in familial breast cancer

Are the same germline mutations in KAT6B also present in other BRCA X families? 42 additional cancers from 26 BRCAx families were tested None of the mutations are present in these families Sequencing entire KAT6B gene see no mutations

Distribution of germline mutations in 26 BRCAx families

Each BRCAx breast cancer family may have its own genetic cause 100% Familial-specific predisposition 40%

Genetic predispositions in familial breast cancer: Same Disease, Different Causes Common predispositions only exist in a portion of familial breast cancer Family-specific predispositions are responsible for many familial breast cancer Family-based approach can identify the unknown predispositions Precision medicine, personalized medicine, familial medicine…. Wen et al. BMC Cancer ;14:470

Contribution University of Nebraska Med Center Yeong C. Kim Bradley Downs Hongxiu Wen Fengxia Xiao Peixian Chen Jiangtao Luo San Ming Wang Creighton University Carrie Snyder Mark Stacey Dina Becirovic Henry Lynch